SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Food and Drug Administration Commissioner Stephen Hahn looks on as President Donald Trump announces that the Food and Drug Administration is issuing an emergency authorization for blood plasma as a coronavirus treatment during a press conference in James S. Brady Briefing Room at the White House on on August 23, 2020 in Washington, D.C. (Photo: Pete Marovich/Getty Images)
In Latest Sign of Covid-19 Politicization, FDA Officials Fired After Director Apologizes for Overstating Plasma Benefits
"The takeover of the FDA by politics and Trump political hacks is something that threatens your life and the lives of everyone you care about."
Aug 28, 2020
Two public relations officials were dismissed from their positions at the Food and Drug Administration Friday following Commissioner Stephen Hahn's decision to walk back his recent claims about convalescent plasma as a treatment for Covid-19.
The agency's chief spokesperson, Emily Miller, only served in her position for 11 days before being ousted. Miller, who previously worked on Sen. Ted Cruz's (R-Texas) reelection campaign and for the right-wing news outlet One America News, was "involved in prepping the commissioner and the press materials for the announcement on the emergency use authorization on convalescent plasma," according to CNN.
"I did recommend that he correct the record. If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing."
--Wayne Pines, fired FDA PR consultant
Earlier this week, Hahn joined President Donald Trump in a press conference in which the president announced that the FDA had given emergency authorization for the use of plasma from patients who have recovered from Covid-19 to treat people who have the illness.
Hahn was rebuked by public health experts for giving approval to the treatment, which has not yet been subjected to randomized, controlled trials--the standard process for testing the efficacy of a drug, treatment, or vaccine.
The commissioner took part in the press conference and gave the authorization after Trump, in numerous statements, accused "the deep state, or whoever, over at the FDA" of standing in the way of approving the treatment in order to hurt the president's reelection chances. Both Dr. Francis Collins and Dr. Anthony Fauci of the National Institutes of Health had cautioned against approving the use of plasma.
At the press conference, Trump claimed convalescent plasma has been "proven to reduce mortality by 35%." According to British palliative care physician Dr. Rachel Clarke, the limited research of the treatment actually shows a reduction of "at most, 3.5%--in a poorly designed study with no control arm."
A day after the press conference, Hahn tweeted that the criticism he received was "absolutely justified" and that "the data show a relative risk reduction not an absolute risk reduction."
Along with Miller, PR consultant Wayne Pines, who had advised Hahn to walk back his claims, was fired from his position at the FDA Friday, the New York Times reported.
"I did recommend that he correct the record," Pines told the Times. "If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing."
The FDA denied that Pines was dismissed because of the public statements Hahn made about convalescent plasma, but critics said both firings were evidence that PR officials have been scapegoated to cover up the agency's failings.
"The most [telling] part of this is not about Emily Miller, but firing the consultant who advised Stephen Hahn to tell the truth," tweeted Eric Topol, a scientist and director of the Scripps Research Translational Institute, who denounced Hahn earlier this week for overstating the effects of plasma.
Rep. Bill Pascrell (D-N.J.) tweeted that the dismissal of the PR officials offers more evidence of the politicization of the FDA during a public health crisis.
"The takeover of the FDA by politics and Trump political hacks is something that threatens your life and the lives of everyone you care about," the congressman wrote.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Two public relations officials were dismissed from their positions at the Food and Drug Administration Friday following Commissioner Stephen Hahn's decision to walk back his recent claims about convalescent plasma as a treatment for Covid-19.
The agency's chief spokesperson, Emily Miller, only served in her position for 11 days before being ousted. Miller, who previously worked on Sen. Ted Cruz's (R-Texas) reelection campaign and for the right-wing news outlet One America News, was "involved in prepping the commissioner and the press materials for the announcement on the emergency use authorization on convalescent plasma," according to CNN.
"I did recommend that he correct the record. If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing."
--Wayne Pines, fired FDA PR consultant
Earlier this week, Hahn joined President Donald Trump in a press conference in which the president announced that the FDA had given emergency authorization for the use of plasma from patients who have recovered from Covid-19 to treat people who have the illness.
Hahn was rebuked by public health experts for giving approval to the treatment, which has not yet been subjected to randomized, controlled trials--the standard process for testing the efficacy of a drug, treatment, or vaccine.
The commissioner took part in the press conference and gave the authorization after Trump, in numerous statements, accused "the deep state, or whoever, over at the FDA" of standing in the way of approving the treatment in order to hurt the president's reelection chances. Both Dr. Francis Collins and Dr. Anthony Fauci of the National Institutes of Health had cautioned against approving the use of plasma.
At the press conference, Trump claimed convalescent plasma has been "proven to reduce mortality by 35%." According to British palliative care physician Dr. Rachel Clarke, the limited research of the treatment actually shows a reduction of "at most, 3.5%--in a poorly designed study with no control arm."
A day after the press conference, Hahn tweeted that the criticism he received was "absolutely justified" and that "the data show a relative risk reduction not an absolute risk reduction."
Along with Miller, PR consultant Wayne Pines, who had advised Hahn to walk back his claims, was fired from his position at the FDA Friday, the New York Times reported.
"I did recommend that he correct the record," Pines told the Times. "If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing."
The FDA denied that Pines was dismissed because of the public statements Hahn made about convalescent plasma, but critics said both firings were evidence that PR officials have been scapegoated to cover up the agency's failings.
"The most [telling] part of this is not about Emily Miller, but firing the consultant who advised Stephen Hahn to tell the truth," tweeted Eric Topol, a scientist and director of the Scripps Research Translational Institute, who denounced Hahn earlier this week for overstating the effects of plasma.
Rep. Bill Pascrell (D-N.J.) tweeted that the dismissal of the PR officials offers more evidence of the politicization of the FDA during a public health crisis.
"The takeover of the FDA by politics and Trump political hacks is something that threatens your life and the lives of everyone you care about," the congressman wrote.
Two public relations officials were dismissed from their positions at the Food and Drug Administration Friday following Commissioner Stephen Hahn's decision to walk back his recent claims about convalescent plasma as a treatment for Covid-19.
The agency's chief spokesperson, Emily Miller, only served in her position for 11 days before being ousted. Miller, who previously worked on Sen. Ted Cruz's (R-Texas) reelection campaign and for the right-wing news outlet One America News, was "involved in prepping the commissioner and the press materials for the announcement on the emergency use authorization on convalescent plasma," according to CNN.
"I did recommend that he correct the record. If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing."
--Wayne Pines, fired FDA PR consultant
Earlier this week, Hahn joined President Donald Trump in a press conference in which the president announced that the FDA had given emergency authorization for the use of plasma from patients who have recovered from Covid-19 to treat people who have the illness.
Hahn was rebuked by public health experts for giving approval to the treatment, which has not yet been subjected to randomized, controlled trials--the standard process for testing the efficacy of a drug, treatment, or vaccine.
The commissioner took part in the press conference and gave the authorization after Trump, in numerous statements, accused "the deep state, or whoever, over at the FDA" of standing in the way of approving the treatment in order to hurt the president's reelection chances. Both Dr. Francis Collins and Dr. Anthony Fauci of the National Institutes of Health had cautioned against approving the use of plasma.
At the press conference, Trump claimed convalescent plasma has been "proven to reduce mortality by 35%." According to British palliative care physician Dr. Rachel Clarke, the limited research of the treatment actually shows a reduction of "at most, 3.5%--in a poorly designed study with no control arm."
A day after the press conference, Hahn tweeted that the criticism he received was "absolutely justified" and that "the data show a relative risk reduction not an absolute risk reduction."
Along with Miller, PR consultant Wayne Pines, who had advised Hahn to walk back his claims, was fired from his position at the FDA Friday, the New York Times reported.
"I did recommend that he correct the record," Pines told the Times. "If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing."
The FDA denied that Pines was dismissed because of the public statements Hahn made about convalescent plasma, but critics said both firings were evidence that PR officials have been scapegoated to cover up the agency's failings.
"The most [telling] part of this is not about Emily Miller, but firing the consultant who advised Stephen Hahn to tell the truth," tweeted Eric Topol, a scientist and director of the Scripps Research Translational Institute, who denounced Hahn earlier this week for overstating the effects of plasma.
Rep. Bill Pascrell (D-N.J.) tweeted that the dismissal of the PR officials offers more evidence of the politicization of the FDA during a public health crisis.
"The takeover of the FDA by politics and Trump political hacks is something that threatens your life and the lives of everyone you care about," the congressman wrote.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.